These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9153616)

  • 21. [Dysimmune neuropathies: current diagnosis and therapy].
    Léger JM; Larue S; Dashi F
    Rev Prat; 2008 Nov; 58(17):1887-9, 1892-4. PubMed ID: 19157204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disorder resembling Guillain-Barré syndrome on initiation of statin therapy.
    Rajabally YA; Varakantam V; Abbott RJ
    Muscle Nerve; 2004 Nov; 30(5):663-6. PubMed ID: 15389662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
    Nagappan R; Barker J
    N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2001; (2):CD002063. PubMed ID: 11406030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guillain-Barre syndrome.
    Walk D
    Surg Neurol; 1997 Mar; 47(3):305-7. PubMed ID: 9068704
    [No Abstract]   [Full Text] [Related]  

  • 26. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
    Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
    Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysaesthesias and dysautonomia: a self-limited syndrome of painful dysaesthesias and autonomic dysfunction in childhood.
    Nass R; Chutorian A
    J Neurol Neurosurg Psychiatry; 1982 Feb; 45(2):162-5. PubMed ID: 7069429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute pandysautonomia and severe sensory deficit with poor recovery. A clinical, neurophysiological and pathological case study.
    Fagius J; Westerberg CE; Olsson Y
    J Neurol Neurosurg Psychiatry; 1983 Aug; 46(8):725-33. PubMed ID: 6886716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic dysautonomia treated with intravenous gammaglobulin.
    Heafield MT; Gammage MD; Nightingale S; Williams AC
    Lancet; 1996 Jan; 347(8993):28-9. PubMed ID: 8531546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guillain-Barré syndrome.
    Evans OB; Vedanarayanan V
    Pediatr Rev; 1997 Jan; 18(1):10-6. PubMed ID: 8993064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute pandysautonomia and acute autonomic and sensory neuropathy].
    Okada F
    Hokkaido Igaku Zasshi; 1989 Jan; 64(1):4-9. PubMed ID: 2656462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
    Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
    Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin.
    Voltz R; Rosen FV; Yousry T; Beck J; Hohlfeld R
    Neurology; 1996 Jan; 46(1):250-1. PubMed ID: 8559387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Guillain-Barré syndrome and acute disseminated encephalomyelitis in the pediatric population.
    Bernard G; Riou E; Rosenblatt B; Dilenge ME; Poulin C
    J Child Neurol; 2008 Jul; 23(7):752-7. PubMed ID: 18354151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peripheral autonomic insufficiency in the Guillain-Barré syndrome].
    Sadekov RA; Oknin VIu; Piradov MA; Popov AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(5-12):62-5. PubMed ID: 1338160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute dysautonomia secondary to autoimmune diseases: efficacy of intravenous immunoglobulin and correlation with a stimulation of plasma norepinephrine levels.
    Dupond JL; Gil H; Bouhaddi M; Magy N; Berthier S; Regnard J
    Clin Exp Rheumatol; 1999; 17(6):733-6. PubMed ID: 10609075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of intravenous immunoglobulins in Guillain-Barré syndrome].
    Ceccarelli M; Assanta N; Chiaravalloti G; Rocopou C; Caiulo VA
    Minerva Pediatr; 1992 May; 44(5):237-40. PubMed ID: 1620076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2010 Jun; (6):CD002063. PubMed ID: 20556755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-Barré syndrome.
    Ansar V; Valadi N
    Prim Care; 2015 Jun; 42(2):189-93. PubMed ID: 25979580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.